CONDITION

Discoid Lupus Erythematosus

Discoid lupus erythematosus is an immune-mediated skin condition in which the body's own immune cells attack the junction where the outer and deeper layers of skin meet. The damage tends to appear in areas exposed to sunlight — most commonly the nose, lips, ears, and around the eyes — and often begins as loss of the normal smooth texture, colour change, or crusting that does not heal in the usual way. Owners often arrive on this page wondering about persistent changes to the nose leather, particularly loss of pigment, scaling, or crusting that may come and go or slowly worsen. In dogs, these changes can sometimes be mistaken for simple sun damage, injury, or infection, but the pattern and location often suggest something happening at a deeper level in the skin. This page explores what signals may be observed, what is happening in the skin when immune cells target the structures at the base of the epidermis, how the condition is investigated through examination and biopsy, and what approaches exist to manage the immune response and protect affected areas.

Why this matters now

Discoid lupus erythematosus most often appears in middle-aged to older dogs, with a median age of onset around seven years, though reported cases range from under two years to senior age and it can emerge at any life stage. Certain breeds, including Collies, Shetland Sheepdogs, German Shepherds, and Siberian Huskies, appear to be over-represented, suggesting a genetic component to susceptibility. The condition is also seen in cats, though less frequently. Sunlight exposure appears to play a role in triggering or worsening the visible changes, which is why the nose and other thinly haired, sun-exposed areas are most often affected.

The condition typically develops gradually over weeks to months, often beginning with subtle changes in the texture or colour of the nose before more obvious crusting or erosion appears. In many cases, the signs may wax and wane, particularly in relation to sunlight exposure or seasonal variation, with some animals experiencing periods of relative stability and others showing steady progression. Without intervention, the changes can become more widespread and the skin surface may lose its normal architecture, though the rate and extent of progression vary considerably between individuals.

Signals & patterns

Early signals

Loss of nasal pigment

The normally dark, pigmented surface of the nose may begin to lighten in patches or diffusely, often starting at the centre or edges. This change in colour can be one of the first visible signs, though it may initially be mistaken for simple depigmentation or seasonal variation.

Change in nasal texture

The nose may lose its usual smooth, slightly rough texture and begin to feel uneven or develop a slightly scaly surface. Owners often notice this when petting or observing their dog closely, as the normal 'cobblestone' appearance of the nose becomes less distinct.

Fine crusting or flaking

Small crusts or flakes may appear on the surface of the nose, sometimes accompanied by a dry or slightly rough feel. These early crusts may be intermittent and can sometimes be gently removed, only to return within days.

Redness at the margins

The edges of the nose or the junction between pigmented and non-pigmented skin may appear pinker or more inflamed than usual. This erythema can be subtle and may be more apparent in certain lighting or after sun exposure.

Later signals

Persistent crusting or erosion

Thicker, adherent crusts may develop, and the underlying skin may appear eroded or raw when crusts are shed or removed. The surface may no longer heal smoothly between episodes, and repeated cycles of crust formation can become a defining pattern.

Ulceration or bleeding

Areas of deeper tissue damage may develop, with open sores or ulcers that may bleed spontaneously or when touched. These lesions can be uncomfortable and may attract secondary bacterial colonisation, which can complicate the appearance further.

Spread beyond the nose

The changes may extend to the lips, eyelids, ears, or other sun-exposed or thinly haired areas, following a similar pattern of depigmentation, crusting, and erosion. This wider distribution can indicate more extensive immune activity.

Click to read about the biological mechanisms

How this is usually investigated

The investigation of suspected discoid lupus erythematosus typically begins with careful examination of the affected skin and a detailed history of when the changes first appeared, how they have progressed, and whether there is any seasonal pattern. Because the visible signs can resemble other skin conditions, including autoimmune diseases, infections, or reactions to sunlight alone, confirming the diagnosis usually requires taking a small sample of affected tissue for microscopic analysis. Additional tests may be used to assess whether changes are confined to the skin or part of a more widespread immune process.

Physical examination

Purpose: A close inspection of the nose, face, ears, and other sun-exposed areas allows the clinician to assess the pattern, distribution, and severity of the skin changes, and to look for signs that might suggest alternative or additional diagnoses.
Considerations: The appearance alone cannot reliably distinguish discoid lupus from other conditions that cause similar crusting, depigmentation, or ulceration. Physical findings guide the choice of further tests but do not confirm the diagnosis.

Histopathology

Purpose: Microscopic examination of a skin biopsy from the affected area typically reveals the characteristic pattern of immune-cell infiltration at the dermo-epidermal junction, apoptosis of basal keratinocytes, and vacuolar degeneration that define discoid lupus erythematosus. The biopsy can also identify features that help exclude other autoimmune skin diseases or infections.
Considerations: The quality and location of the biopsy sample influence how clearly the diagnostic features are seen, and early or very advanced lesions may show less specific changes. The biopsy provides structural detail but does not measure the extent of immune activity or predict how the condition will progress in an individual animal.

Direct immunofluorescence or immunohistochemistry

Purpose: This technique detects deposits of antibodies and complement proteins at the basement membrane zone of affected skin, a pattern often called the lupus band test. A positive result supports the diagnosis and reflects the humoral component of the immune response.
Considerations: The test requires special handling of the biopsy sample and is not available in all laboratories. A positive result is common in discoid lupus but can also occur in other autoimmune skin conditions, and a negative result does not rule out the diagnosis if the histopathological pattern is otherwise typical.

Antinuclear antibody (ANA) testing

Purpose: This blood test detects antibodies directed against components of cell nuclei and can help distinguish discoid lupus, which is usually confined to the skin, from systemic lupus erythematosus, which involves multiple organ systems.
Considerations: Most dogs with discoid lupus erythematosus have a negative or low-titre ANA result, supporting that the immune activity is localised to the skin. A positive result may prompt further investigation for systemic involvement, though occasional dogs with discoid lupus test positive without having signs of disease elsewhere.

Complete blood count

Purpose: A blood count assesses red cells, white cells, and platelets, helping to identify cytopenias or other abnormalities that would suggest systemic autoimmune disease rather than skin-limited discoid lupus.
Considerations: In uncomplicated discoid lupus, the blood count is typically normal. Abnormalities such as anaemia, low platelet count, or low white cell count warrant further investigation for systemic lupus erythematosus or other multisystem immune conditions.

Options & trade-offs

Management of discoid lupus erythematosus is usually tailored to the severity of the skin changes, the impact on the individual animal's comfort and function, and what is practical for the owner to maintain over the long term. Most approaches aim to reduce immune-mediated inflammation in the skin and limit further ultraviolet-induced damage, though the degree of control achieved varies between individuals. Because the condition tends to be chronic and may fluctuate with seasons or sun exposure, many animals require ongoing management rather than a single course of treatment.

Topical corticosteroids or tacrolimus

Creams or ointments containing corticosteroids or the calcineurin inhibitor tacrolimus can be applied directly to affected areas to reduce local inflammation and immune activity. These are often used for dogs with mild to moderate changes confined to the nose or a small area of skin. The medication is typically applied once or twice daily, and the frequency may be reduced once the skin appearance improves.

Trade-offs: Topical treatments avoid systemic side effects but require the owner to handle the affected area regularly, which can be challenging if the skin is painful or the dog is reluctant. The nose's exposure to licking, rubbing, and the environment may reduce how much medication remains in contact with the skin, and some animals do not respond adequately to topical therapy alone.

Oral corticosteroids

Prednisolone or other systemic corticosteroids may be used when topical treatment is insufficient or when lesions are more widespread. An initial higher dose is often given to bring the inflammation under control, followed by gradual reduction to the lowest dose that maintains improvement. Some dogs require long-term low-dose therapy, whilst others can be managed with intermittent courses during flare periods.

Trade-offs: Systemic corticosteroids can produce side effects including increased thirst, appetite, and urination, and long-term use carries risks such as muscle loss, thinning of the skin, and increased susceptibility to infection. The need for ongoing medication and monitoring means this approach suits owners who can commit to regular follow-up and dose adjustments.

Oral immunomodulatory drugs

Medications such as azathioprine, ciclosporin, or mycophenolate may be considered when corticosteroids alone are not adequately controlling the condition, when side effects from steroids are problematic, or when the goal is to reduce the steroid dose. These drugs work by different mechanisms to dampen the immune response and are often used in combination with lower doses of corticosteroids. Regular monitoring of blood counts and liver enzymes is usually required.

Trade-offs: Immunomodulatory drugs can take several weeks to show effect, and their use requires careful monitoring for side effects such as bone marrow suppression, gastrointestinal upset, or liver changes. The need for repeated blood tests and the cost of the medications may be limiting factors for some owners, and not all animals respond equally well.

Vitamin E and essential fatty acid supplementation

High doses of vitamin E, sometimes combined with omega-3 and omega-6 fatty acids, have been used as adjunctive therapy in some dogs with discoid lupus. The mechanism is thought to involve antioxidant effects and modulation of inflammatory pathways in the skin. These supplements are generally given alongside other treatments rather than as sole therapy.

Trade-offs: The evidence supporting vitamin E and fatty acids is less robust than for immunosuppressive drugs, and response varies widely between individuals. They are generally well tolerated, though high doses of vitamin E can occasionally interfere with blood clotting, and the benefit may be modest or take months to become apparent.

Ultraviolet light protection

Limiting sun exposure, particularly during peak ultraviolet hours, and using pet-safe sunscreens on the nose and other affected areas can help reduce flare-ups and slow progression. Some owners adjust walking times to early morning or late evening and provide shaded rest areas. Tattooing of the depigmented nose with medical-grade pigment has occasionally been used to provide a physical barrier to ultraviolet light.

Trade-offs: Behavioural adjustments and sunscreen application require consistent daily effort and may not be fully practical for all households or climates. Sunscreens must be safe for animals that lick their noses, and even with good compliance, ultraviolet protection alone is rarely sufficient to control moderate to severe disease without concurrent medical therapy.

Common misconceptions

Misconception:

"Discoid lupus erythematosus will eventually spread to involve internal organs and become systemic lupus."

Reality:

Discoid lupus erythematosus is generally a skin-limited condition, and progression to systemic lupus erythematosus is uncommon. Most dogs with discoid lupus remain healthy apart from the skin changes, though monitoring for signs of systemic involvement is part of routine follow-up in some cases.

Misconception:

"Once the nose has lost its pigment, the colour will never return."

Reality:

Whilst pigment loss can be persistent, some dogs regain partial or full pigmentation if the inflammation is brought under control early and maintained at a low level. The degree of recovery varies widely, and in cases with advanced scarring or long-standing disease, repigmentation may be limited or absent.

Misconception:

"Discoid lupus is caused by excessive sun exposure in the same way that sunburn damages skin."

Reality:

Ultraviolet light appears to trigger or worsen discoid lupus by altering skin proteins in a way that provokes an abnormal immune response, rather than simply causing direct thermal or radiation injury. The condition is driven by immune-mediated inflammation, and sun exposure acts as a modifying factor in genetically predisposed individuals rather than the sole cause.

Related conditions

Pemphigus

Pemphigus foliaceus is another autoimmune skin condition in which the immune system attacks components of the skin, though in pemphigus the target is the connections between skin cells rather than the dermal–epidermal junction. Both conditions can produce crusting and scaling, particularly on the face, and may be considered alongside one another when investigating autoimmune skin disease.

Sebaceous Adenitis

Sebaceous adenitis involves immune-mediated inflammation directed at the sebaceous glands, and in some cases can produce scaling and crusting that may resemble discoid lupus, particularly around the head. Both conditions reflect an immune process targeting skin structures, though the pattern of tissue involvement and distribution tends to differ.

Feline Calicivirus

Feline calicivirus can cause ulceration and crusting around the nose and mouth in cats, and may occasionally be considered in the differential diagnosis when a cat presents with nasal lesions. Discoid lupus in cats is less common than in dogs, and infectious causes such as calicivirus are often explored first.

Squamous Cell Carcinoma in Cats

Squamous cell carcinoma in cats often affects sun-exposed, lightly pigmented areas such as the nose and ears, and the early changes—loss of pigment, crusting, or texture change—can sometimes resemble the presentation of discoid lupus. Both conditions may be influenced by ultraviolet exposure, though the underlying process and progression differ.

Histiocytoma

Pyoderma describes bacterial infection of the skin, and in some cases secondary bacterial colonisation can complicate discoid lupus when the skin barrier is disrupted by crusting or ulceration. Distinguishing primary autoimmune change from secondary infection may require careful assessment and sometimes culture.

Understanding how the immune system can target the skin in localised ways may open questions about other patterns of immune-mediated disease, both within the skin and elsewhere in the body. The pillar on Immune and Inflammatory Health explores these broader themes. For animals receiving long-term immunosuppressive therapy, familiarity with the signs that might suggest infection or other side effects can inform conversations at routine appointments.

Last reviewed: 1 July 2026 · Dr Alastair Greenway MRCVS